Skip to main content
SpringerLink
Log in

Aspirin thromboprophylaxis of asymptomatic antiphospholipid-positive subjects

  • CE - Letter to the Editor
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Gerosa M, Chighizola G, Meroni PG (2008) Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies? Yes (in some cases). Intern Emerg Med 3:201–203

    Article  PubMed  Google Scholar 

  2. Finazzi G (2008) Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies? No. Intern Emerg Med 3:197–200

    Article  PubMed  Google Scholar 

  3. Giron-Gonzalez JA, Garcia del Rio E, Rodriguez C, Rodriguez-Martorell J, Serrano A (2004) Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals. J Rheumatol 31:1560–1567

    PubMed  Google Scholar 

  4. Galli M, Finazzi G, Duca F, Norbis F, Moia M (2000) The G1691A mutation of factor V, but not the G20210A mutatiin of factor II or the C677T mutation of methylenethetrahydrofolate reductase genes, is associated with venous thrombosis in patients with lupus anticoagulants. Br J Haematol 108:865–870

    Article  PubMed  CAS  Google Scholar 

  5. Glynn RJ, Ridker PM, Goldhaber SZ, Buring JE (2007) Effect of low-dose aspirin on the occurrence of venous thromboembolism: a randomized trial. Ann Intern Med 147:525–533

    PubMed  Google Scholar 

  6. Mari D, Mannucci PM, Coppola R, Bottasso B, Bauer KA, Rosenberg RD (1995) Hypercoagulability in centenarians: the paradox of successful aging. Blood 85:3144–3149

    PubMed  CAS  Google Scholar 

  7. Galli M, Luciani D, Bertolini G, Barbui T (2003) Lupus anticoagulants are stronger risk factors of thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 101:1827–1832

    Article  PubMed  CAS  Google Scholar 

  8. Galli M, Luciani D, Bertolini G, Barbui T (2003) Antiβ2-glycoprotein I, antiprothrombin antibodies and the risk of thrombosis in the antiphospholipid syndrome. Blood 102:2717–2723

    Article  PubMed  CAS  Google Scholar 

  9. Horbach DA, van Oort E, Derksen RHWM, de Groot PG (1998) The contribution of anti-prothrombin antibodies to the lupus anticoagulant activity—discrimination between functional and non-function anti-prothrombin antibodies. J Thromb Haemost 79:790–795

    CAS  Google Scholar 

  10. Simmelink MJ, Derksen RHWM, Arnout J, de Groot PG (2003) A simple method to discriminate between β2-glycoprotein I and prothrombin-dependent lupus anticoagulants. J Thromb Haemost 1:740–747

    Article  PubMed  CAS  Google Scholar 

  11. Pengo V, Biasiolo A, Pegoraro C, Iliceto S (2004) A two-step coagulation test to identify aβ2-glycoprotein I lupus anticoagulants. J Thromb Haemost 2:702–707

    Article  PubMed  CAS  Google Scholar 

  12. De Laat HB, Derksen RHWM, Urbanus RT, Roest M, de Groot PG (2004) β2-glycoprotein I-dependent lupus anticoagulant highly correlates with thrombosis in the antiphospholipid syndrome. Blood 104:3598–3602

    Article  PubMed  Google Scholar 

  13. De Laat B, Derksen RHWM, Urbanus RT, de Groot PG (2005) IgG antibodies that recognize epitope Gly40-Arg43 in domain I of β2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis. Blood 105:1540–1545

    Article  PubMed  Google Scholar 

  14. Rix P, Stentoft J, Aunsholt NA, Dueholm M, Tilma KA, Høier-Madsen M (1992) Lupus anticoagulant and anticardiolipin antibodies in an obstetric population. Acta Obstet Gynecol Scand 71:605–609

    Article  PubMed  CAS  Google Scholar 

  15. Schved JF, Dupuy-Fons C, Biron C, Quére I, Janbon C (1994) A prospective epidemiological study on the occurrence of antiphospholipid antibody: the Montpellier antiphospholipid (MAP) study. Haemostasis 24:175–182

    PubMed  CAS  Google Scholar 

Download references

Conflict of interest statement

The author declares that she has no conflict of interest related to the publication of this manuscript.

Author information

Authors and Affiliations

  1. Divisione di Ematologia, Ospedali Riuniti, Largo Barozzi, 1, 24128, Bergamo, Italy

    Monica Galli

Authors
  1. Monica Galli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Monica Galli.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Galli, M. Aspirin thromboprophylaxis of asymptomatic antiphospholipid-positive subjects. Intern Emerg Med 4, 63–64 (2009). https://doi.org/10.1007/s11739-008-0203-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-008-0203-6

Keywords

Search

Navigation